MORTALITY AND MORBIDITY IN TREATED HYPERTENSIVE TYPE-2 DIABETIC-PATIENTS WITH MICROPROTEINURIA OR MACROPROTEINURIA

被引：19

作者：

SAWICKI, PT ^{[1
]}

MUHLHAUSER, I ^{[1
]}

DIDJURGEIT, U ^{[1
]}

REIMANN, M ^{[1
]}

BENDER, R ^{[1
]}

BERGER, M ^{[1
]}

机构：

[1] UNIV DUSSELDORF,COLLABORATING CTR DIABET,WHO,MED DEPT METAB DIS & NUTR,DUSSELDORF,GERMANY

来源：

DIABETIC MEDICINE | 1995年 / 12卷 / 10期

关键词：

DIABETES MELLITUS; PROTEINURIA; HYPERTENSION; MORTALITY; MORBIDITY;

D O I：

10.1111/j.1464-5491.1995.tb00392.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In order to describe the natural history of high risk diabetic patients treated for hypertension we have followed a sequential sample of 100 hypertensive Type 2 diabetic patients with elevated urinary protein excretion (greater than or equal to 60 mg 24 h(-1)) for a period of 1-7 years. Antihypertensive treatment was instituted in all patients and, in addition, the patients were offered the possibility of participation in an intensified antihypertensive therapy programme. After a mean follow-up of 4 years overall mortality was 13 %. Nineteen percent of all patients experienced a cardiovascular event and 7% a cerebrovascular event. In conclusion, in this study the overall mortality was lower that previously reported in proteinuric Type 2 diabetic patients. Antihypertensive treatment may account for this outcome.

引用

页码：893 / 898

页数：6

共 24 条

[1]

Pyorala K., Laakso M., Macrovascular disease in diabetes mellitus, Diabetes Epidemiological Perspective, pp. 183-247, (1983)

[2]

Jarrett RJ, Type 2 (non‐insulin‐dependent) diabetes mellitus and coronary heart disease—chicken egg, or neither, Diabetologia, 28, pp. 99-102, (1984)

[3]

Panzram G., Mortality and survival in type 2 (non‐insulin dependent) diabetes mellitus, Diabetologia, 30, pp. 123-131, (1987)

[4]

Gall MA, Rossing P., Skott P., Damsbo P., Vaag A., Bech K., Et al., Prevalence of micro‐ and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non‐insulin‐dependent) diabetic patients, Diabetologia, 34, pp. 655-661, (1991)

[5]

Yudkin JS, Forrest RD, Jackson CA, Microalbuminuria as predictor of vascular disease in non‐diabetic subjects, Lancet, 2, pp. 530-533, (1988)

[6]

Damsgaard EM, Froland A., Jorgensen OD, Mogensen CE, Microalbuminuria as predictor of increased mortality in elderly people, Br Med J, 300, pp. 297-300, (1990)

[7]

Borch-Johnsen K., Andersen PK, Deckert Z., The effect of proteinuria on relative mortality in type‐1 (insulin‐dependent) diabetes mellitus, Diabetologia, 28, pp. 590-596, (1985)

[8]

Stiegler H., Standl E., Schulz K., Roth R., Lehmacher W., Morbidity, mortality and albuminuria in Type 2 diabetic patients: a three year prospective study of a random cohort in general practice, Diabetic Med, 9, pp. 646-653, (1992)

[9]

Neil A., Hawkins M., Potok M., Thorogood M., Cohen D., Mann J., A prospective population‐based study of microalbuminuria as predictor of mortality in NIDDM, Diabetes Care, 16, pp. 996-1003, (1993)

[10]

Mattock M., Morrish NJ, Viberti GC, Keen H., Fitzgerald AP, Jackson G., Prospective study of microalbuminuria as predictor of mortality in NIDDM, Diabetes, 41, pp. 736-741, (1992)

← 1 2 3 →